![]() |
Imlygic™, the First Oncolytic Viral Therapy in the US...
January 1, 2016 - Featured , In the News / Politics By: Gabrielle Plaia, PharmD Candidate Class of 2016 – On Oct. 27 2015, the Food and Drug Administration announced the approval of talimogene laherparepvec, referred to by its brand name ImlygicTM, with an indication for local treatment of melanoma lesions that cannot be removed completely by initial surgery. The drug was created by Amgen.1 This… |
![]() |
Dabigatran Antidote Provides New Option for Targeted An...
December 1, 2015 - Featured , In the News / Politics By: Svetlana Akbasheva, Staff Editor – Dabigatran etexilate mesylate (Pradaxa®) is an oral anticoagulant that functions as a direct thrombin inhibitor. Like other anticoagulants, this medication carries the risk of serious bleeding and must be stopped temporarily before any surgical procedures, with the length of time depending on a patient’s creatinine clearance and invasiveness of… |
![]() |
States Expand Access to Naloxone...
December 1, 2015 - Featured , In the News / Politics By: Svetlana Akbasheva, Staff Editor – Naloxone (Narcan®) is a rapid-acting, potentially life-saving drug for acute opioid overdose. An opioid antagonist, naloxone displaces opioids from their receptors and helps reverse their effects, the most dangerous of which is respiratory depression.1 According to the Centers for Disease Control and Prevention, over 22,000 deaths in the United… |
![]() |
Novel Anticoagulant Approved For Use in Embolism Preven...
December 1, 2015 - Featured , In the News / Politics By: Maryam Ahmed and Lyudmila Krivovyaz, Pharm.D Candidates, c/o 2016 – Each year, more than 795,000 Americans suffer from a stroke, with almost 130,000 of those resulting in death.1 Traditionally, warfarin sodium (Coumadin®) has always been the drug of choice for treatment and prevention of clot formation. Over the last couple of years, however, newer… |
![]() |
New Therapeutic Options for IBS-D...
November 1, 2015 - Featured , In the News / Politics By: Benedette Cuffari, B.S. of Toxicology Candidate 2016 – Affecting 10%-15% of the population in Western countries, irritable bowel syndrome (IBS) is most often categorized by altered bowel habits involving chronic or recurrent diarrhea or constipation.1 IBS patients with chronic diarrhea, sometimes referred to as IBS-D, exhibit abdominal pain and/or discomfort in addition to loose… |
![]() |
Idiopathic Pulmonary Fibrosis: Treating a Mystery...
November 1, 2015 - Featured , In the News / Politics By: Svetlana Akbasheva, Section Editor – Idiopathic pulmonary fibrosis (IPF) is a devastating condition in which the lungs become thick and tough with scar tissue and progressively lose their ability to efficiently deliver oxygen to the blood.1 That the disease has no established cause can make diagnosis difficult. However, the 2011 ATS/ERS/JRS/ALAT guidelines2 provide three… |
![]() |
Even the FDA follows Kim!...
November 1, 2015 - Featured , In the News / Politics By: Nancy Simon, PharmD Candidate 2016 – Many of you may have seen Kim Kardashian West’s Instagram posts – most of which are ‘selfies,’ but recently, a particular post caught the attention of the Food and Drug Administration (FDA) this past August 2015. Kim posted a picture with Diclegis® (doxylamine succinate and pyridoxine hydrochloride), claiming… |
![]() |
Probiotics as a possible treatment antibiotic-associate...
November 1, 2015 - Featured , In the News / Politics By: Holly Sokol, PharmD Candidate 2020 – Antibiotic-associated diarrhea (AAD) can occur due to antibiotics changing the elements of the gut and thereby, increasing an organism’s inhabitance. Diarrhea is common in as many as 40% of critically ill patients. An even greater problem is Clostridium difficile (antibiotics-associated) becoming a leading cause of mortality in hospital-related… |
![]() |
New Treatment Option for Diabetic Retinopathy...
October 1, 2015 - Featured , In the News / Politics By: Sylva Ohanian, Staff Writer – The FDA recently approved aflibercept (Eylea®) injection for the treatment of diabetic retinopathy (DR) in patients with diabetic macular edema (DME).1 Diabetic retinopathy is the most common diabetic eye disease and is a leading cause of blindness in American adults. It is generally characterized by changes occurring in the… |
![]() |
Cytisine: Another Option for Smoking Cessation...
October 1, 2015 - Featured , In the News / Politics By: Andrew Leong, Staff Writer – Quitting smoking greatly reduces the risk of many diseases such as lung cancer, coronary heart disease, and stroke, all of which increase morbidity and mortality in patients. Currently in North America, there are three main pharmacological therapies used in the management of smoking cessation. The most recognizable one, nicotine… |
![]() |
Aripiprazole (Abilify®) Approved...
October 1, 2015 - Featured , In the News / Politics By: Sang Hyo Kim, Section Editor – On April 28, 2015, the U.S. Food and Drug Administration approved aripiprazole, the generic of Abilify®.1 Aripiprazole tablets are used to treat patients with schizophrenia and bipolar disorder.1 Although Otsuka Pharmaceuticals, the manufacturer of Abilify®, tried to block generic competition by requesting a temporary restraining order on one… |
![]() |
FDA Approves First Tissue Adhesive for Internal Use...
October 1, 2015 - Featured , In the News / Politics By: Azia Tariq, Section Editor – The U.S. Food and Drug Administration (FDA) has approved TissuGlu®, the first tissue adhesive approved for internal use. William Maisel, M.D., M.P.H., Deputy Director of Science at FDA’s Center for Devices and Radiological Health states, “The FDA’s approval of the first synthetic adhesive for internal use will help some… |
![]() |
Sodium Zirconium Cyclosilicate: A Novel Potassium Binde...
September 1, 2015 - Featured , In the News / Politics By: Andrew Leong, Staff Writer – Hyperkalemia is defined as a serum potassium level of greater than 5.0 mmol/L.1 In a majority of cases, the cause is renal in nature with over half of all patients with hyperkalemia suffering from chronic kidney disease.2 Other causes include an increase in diet potassium, tumor lysis syndrome, and… |
![]() |
Stiolto™ Respimat® Enters Market...
September 1, 2015 - Featured , In the News / Politics By: Sylva Ohanian, Staff Writer – Chronic obstructive pulmonary disease (COPD) is a serious yet treatable lung disease, which affects 210 million people worldwide and is expected to be the third leading cause of death in the world by 2030.1 Symptoms, such as wheezing and coughing, can negatively impact breathing, especially during daily activities.1, 2… |
![]() |
Lidocaine Patch: A Topical Analgesic for Treatment for ...
September 1, 2015 - Featured , In the News / Politics By: Irene Li, PharmD Candidate c/o 2016 – Postherpetic neuralgia is the most common chronic complication of herpes zoster that affects one million people annually in the United States.1 It is defined as dermatomal pain lasting at least 90 days after the appearance of an acute herpes zoster rash. The rash is usually unilateral. Although… |
![]() |
Stem Cells May Halt Progression of Multiple Sclerosis...
August 1, 2015 - Featured , In the News / Politics By: Nehali Parikh, PharmD Candidate c/o 2016 – Multiple sclerosis (MS) is an autoimmune disease that results in interrupted neurotransmission throughout the body. It occurs when the immune system mistakenly attacks myelin, the insulating layer surrounding nerve cells, causing the formation of scar tissue, called sclerosis. Fatigue, numbness, tingling, difficulty in walking, and dizziness are… |
![]() |
Miltefosine (Impavido®) Approved to Treat Tropical Dis...
August 1, 2015 - Featured , In the News / Politics By: Sang Hyo Kim, Staff Editor – On March 19, 2014, the U.S Food and Drug Administration (FDA) approved miltefosine (Impavido®) for the treatment of leishmaniasis. Leishmaniasis is a disease caused by leishmania, a parasite that is transmitted to humans through sand fly bites. Although the majority of people affected with leishmaniasis are from tropical… |
![]() |
Meet Corlanor®: A New Drug for Chronic Heart Failure...
August 1, 2015 - Featured , In the News / Politics By: Svetlana Akbasheva, Staff Editor – For years, the medications that have been the mainstay of therapy for chronic heart failure have been angiotensin converting enzyme (ACE) inhibitors (or angiotensin receptor blockers), beta-blockers, loop diuretics, and aldosterone antagonists, with the occasional addition of digoxin or the hydralazine/isosorbide dinitrate combination.1 Now, a novel medicine is trying… |
![]() |
Treatment Options for Restless Legs Syndrome...
July 1, 2015 - Featured , In the News / Politics By: Svetlana Akbasheva, Staff Editor – Restless Legs Syndrome (RLS or Willis-Ekbom disease) is a condition that affects an estimated 2 to 3% of adults in the United States.1 Patients with RLS experience a strong urge to move the legs, which is more prevalent at rest and is usually alleviated by physical movement. Symptoms… |
![]() |
Illegal Sale of Drugs Online...
July 1, 2015 - Featured , In the News / Politics By: Benedette Cuffari, BS Toxicology Candidate, ‘16 – “Initial Prescription Free,” “FDA Approved,” “Save Thousands!” and “Our Generic Drugs are Identical to Those Sold in the U.S.,” are some of the many advertising tools that thousands of websites around the world have been using to lure customers into buying illegal pharmaceuticals online. The U.S. Food… |
![]() |
When Technology and Medicine Unite...
July 1, 2015 - Featured , In the News / Politics By: Tyler Valente, PharmD Candidate c/o 2016 – A growing trend within our progressive society is the advancement of technology. Over the past few years, inventions that were mere fantasies just a decade or two ago have become a reality. Within the medical field, progress can be seen particularly in the development of medical devices.… |
![]() |
Assessing Risks versus Benefits in Initiating Triple An...
June 1, 2015 - Featured , In the News / Politics By: Jacqueline Chirico, PharmD Candidate c/o 2016 – A dilemma that many clinicians face when treating patients with cardiac problems is determining the appropriateness of initiating triple antithrombotic therapy. While this is appropriate in a select patient population, it is important to understand which patients fall in this category and what risks and benefits should… |
![]() |
New FDA Approved Treatment in Patients With Hypoparathy...
June 1, 2015 - Featured , In the News / Politics By: Dimitrios Savva, PharmD Candidate c/o 2016 – Hypoparathyroidism is a rare disease that affects approximately 60,000 people in the United States.1 People diagnosed with hypoparathyroidism are characterized as having insufficient levels of parathyroid hormone (PTH).2 A person with this disease does not produce or secrete enough of PTH, leading to a decreased level of… |
![]() |
Seeing is Believing: A Look at VEGF Inhibitors for Diab...
June 1, 2015 - Featured , In the News / Politics By: Svetlana Akbasheva, Staff Editor, PharmD Candidate c/o 2016 – Diabetes is one of the biggest health problems in the United States, with the 2014 National Diabetes Statistics Report stating that 9.3% of the population, or over 29 million people, has the disease.1 One of the major complications of uncontrolled diabetes mellitus is diabetic retinopathy,… |
![]() |
Magic Mushrooms: The Future of Smoking Cessation?...
May 1, 2015 - Featured , In the News / Politics By: Maximilian Magun, PharmD Candidate c/o 2016 – While the harm in smoking is well known, quitting is easier said than done. Prescription and over-the counter nicotine replacement therapies (e.g. nicotine patch, gum, inhaler, nasal spray, lozenge), as well as oral tablets (e.g. Zyban™, Chantix®) have mediated success for some. In fact, when used correctly,… |
![]() |
An Aspirin a Day? New Study Assesses Rate of Inappropri...
May 1, 2015 - Featured , In the News / Politics By: Svetlana Akbasheva, Staff Writer – Aspirin 81 mg, or “baby” aspirin, has become almost ubiquitously known as being “heart-healthy” and for playing a role in preventing heart attacks and strokes. With cardiovascular disease reigning as the number one cause of death worldwide, more than 50 million adults in the United States currently take daily… |
![]() |
Great Promise for Factor Xa Inhibitor Antidote: Andexan...
May 1, 2015 - Featured , In the News / Politics By: Galina Perel, PharmD Candidate c/o 2016 – Andexanet alfa’s has achieved great advancement in part one of the Phase 3 ANNEXA-A study conducted by Portola Pharmaceuticals. The study demonstrated the effects of andexanet alfa being the proposed antidote to the oral anticoagulant Factor Xa inhibitor: apixaban (Eliquis©).1 Apixaban received FDA approval in late 2012… |
![]() |
Working Towards an Artificial Pancreas...
April 1, 2015 - Featured , In the News / Politics By: Maryam Ahmed and Tyler Valente, PharmD Candidates c/o 2016 – Diabetes Mellitus is a condition in which the body cannot properly maintain its blood glucose. There are two types of Diabetes Mellitus (DM), Type 1 and Type 2, which vary greatly but each have at the crux an inability to transport glucose into the… |
![]() |
The Role of Pharmacists in the EVD Outbreak...
April 1, 2015 - Featured , In the News / Politics By: Azia Tariq, Section Editor – Reported in March 2014, the current Ebola virus disease (EVD) outbreak has become the deadliest outbreak of its kind since the disease’s initial discovery in 1976. As of April 24, 2015, the epidemic has spread to numerous countries across West Africa including Guinea, Liberia, and Sierra Leone resulting in… |
![]() |
Injectable Naltrexone for Smoking Cessation...
April 1, 2015 - Featured , In the News / Politics By: Jacqueline Meaney, PharmD Candidate c/o 2015, University at Buffalo: School of Pharmacy and Pharmaceutical Sciences – Extended release naltrexone (XR-NTX), marketed as once-monthly IM Vivitrol®, is currently FDA approved for use in treating both alcohol and opiate dependence. Naltrexone is a mu-opioid receptor antagonist that blocks the euphoric effect of heroin and prescription opioids. Naltrexone… |
![]() |
Fifth Time’s a Charm?...
March 1, 2015 - Featured , In the News / Politics Fifth Time’s a Charm? By: Sylva Ohanian, Staff Writer – Liraglutide (Saxenda®) has recently been approved by the FDA for the treatment of chronic weight management in adult patients.1 The indication is specified for those with an initial body mass index (BMI) of 30 kg/m2 or greater (obese) or 27 kg/m2 or greater (overweight) in… |
![]() |
Early Use of Antibiotics Tied to an Increased Risk of P...
March 1, 2015 - Featured , In the News / Politics By: Fatima Elzin, PharmD Candidate c/o 2015 – According to the Centers for Disease Control and Prevention, the prevalence of asthma has risen dramatically in the past two to three decades.1 In the United States, 6.8 million children were diagnosed with asthma in 2012.1 Recent data suggests that this increase in children with asthma may… |
![]() |
How Many Drugs is Too Many?...
March 1, 2015 - Featured , In the News / Politics How Many Drugs is Too Many? By: Caitlyn Cummings, PharmD Candidate c/o 2016 and Ruby Lee, PharmD Candidate c/o 2017 – In Dina Spector’s Business Insider article, “The World’s 2nd-Smartest Man Reveals The ‘Brain Drugs’ That He Thinks Make Him Smarter,” the daily medications taken by Rick Rosner, said genius, are revealed.1 There are unsubstantial… |
![]() |
Harvoni™ – First Combination Pill to Treat Hepa...
February 1, 2015 - Featured , In the News / Politics By: Sebanti Bhowmik and Elissa Tam, PharmD Candidates c/o 2015 – On October 10, 2014, the Food and Drug Administration approved ledipasvir-sofosbuvir (Harvoni™) to treat chronic hepatitis C virus (HCV) genotype 1 infection in adults. Harvoni™, marketed by Gilead Sciences, consists of Gilead’s sofosbuvir (Sovaldi™) and a new drug, ledipasvir.1 Harvoni™ is the first combination… |
![]() |
Prevalence of Psychiatric Disorders in the United State...
February 1, 2015 - Featured , In the News / Politics By: Jacqueline Meaney, PharmD Candidate c/o 2015, University at Buffalo: School of Pharmacy and Pharmaceutical Sciences – Psychiatric disorders are common in the United States, as nearly half of all Americans will meet the criteria for an anxiety disorder, mood disorder, impulse-control disorder or substance abuse disorder at some point in their lifetime. It is estimated… |
![]() |
Use of Complementary and Alternative Medicine in Oncolo...
February 1, 2015 - Featured , In the News / Politics By: Nicollette Pacheco, Staff Editor [Graphics-focused] – With an increase in the use of alternative medicine in the United States, the field of oncology is seeing a rise in the use of unconventional methods to treat symptoms in a wide range of cancers. Since 1990, it has been found that an increasing number of patients… |
![]() |
Usage of Codeine in Pediatric Patients...
January 1, 2015 - Featured , In the News / Politics By: Azia Tariq, Section Editor – With the deaths of thirteen pediatric patients undergoing tonsillectomy and/or adenoidectomy occurring post operation between 1969 to 2012, the Food and Drug Administration (FDA) reviewed the safety of codeine in children in its August 2012 Drug Safety Communication. The FDA subsequently issued a black box warning and a contraindication… |
![]() |
No More ABCs: FDA Issues Final Rule on Pregnancy and La...
January 1, 2015 - Featured , In the News / Politics By: Svetlana Akbasheva, Staff Writer – Pregnancy categories in drug labeling were created in order to facilitate decisions on a medication’s use during pregnancy. With only five possibilities – A, B, C, D, or X – they provided a quick and simple reference regarding a medication’s teratogenic potential. However, in practice this grading system has… |
![]() |
Using Bacteriophage Enzymes to Stay One Step Ahead of M...
December 1, 2014 - Featured , In the News / Politics By: Davidta Brown, Copy Editor [Content-Focused] – It’s difficult to have a discussion about antibiotics without mentioning the developing crisis of antibiotic-resistance. Pathogens like MRSA (methicillin-resistant Staphylococcus aureus) have become a part of the general public’s consciousness – a household name and a community-acquired “superbug.” With the last new class of antibiotics developed in the… |
![]() |
Recombinant Factor IX (Alprolix) Brings Hope for Hemoph...
December 1, 2014 - Featured , In the News / Politics By: Benedette Cuffari, BS Toxicology Candidate c/o 2015 – Hemophilia B is an inherited bleeding disorder that is caused by a substantially reduced or complete lack of blood clotting factor IX. Therefore, people suffering from hemophilia B experience bleeding episodes that cause pain, irreversible joint damage, and life threatening hemorrhages. Approximately 28,000 people are currently… |
![]() |
FDA Defends Generic Drug Labeling Plan...
December 1, 2014 - Featured , In the News / Politics By: Nancy Simon, PharmD c/o 2016 – Last November, the Food and Drug Administration (FDA) submitted a proposal for a Generic Drug Labeling Plan. This new plan will allow generic drug companies to use the same process as the one used by brand drug companies to update their medication labels to reflect new safety information.1… |
![]() |
The Silver Age of Antibiotics...
November 1, 2014 - Featured , In the News / Politics By: Andrew Leong, Staff Writer — This year, the FDA approved three new antibiotics to treat acute bacterial skin and skin structure infections (ABSSSI) caused by Staphylococcus aureus, including MRSA. They are dalbavancin (DalvanceTM), tedizolid phosphate (SivextroTM), and oritavancin (OrbactivTM). Dalbavancin was approved on May 23, 2014 and is administered intravenously in two doses (1000… |
![]() |
Pradaxa® vs Warfarin...
November 1, 2014 - Featured , In the News / Politics By: Kevin Lin, PharmD Candidate c/o 2015 — The FDA recently completed an observational cohort study that compared Pradaxa® (dabigatran) to warfarin for rates of ischemic stroke, intracranial hemorrhage, major gastrointestinal bleed, myocardial infarction, and death. The study enrolled more than 134,000 patients, with 64% over the age of 65 and found a lower risk… |
![]() |
Accountable Care Organizations...
November 1, 2014 - Featured , In the News / Politics By: Stephanie Chiu and Elissa Tam, PharmD Candidates c/o 2015 — According to the Dartmouth Atlas project, health care spending in the United States has risen dramatically and yet health outcomes are not improving; meanwhile, many other countries that spend far less per person than the United States have better health outcomes.1 Studies have since… |
![]() |
FDA-Approved Afrezza: An Inhaled Alternative to Injecta...
October 1, 2014 - Featured , In the News / Politics By: Elissa Tam, PharmD Candidate c/o 2015 – Patients with Type 1 or Type 2 diabetes who cannot control their glucose levels simply by taking oral medications have to inject insulin daily. They also have to measure their glucose levels by using strips and lancets on a regular basis. For patients, especially elderly ones, the… |
![]() |
Combating Counterfeit Drugs...
October 1, 2014 - Featured , In the News / Politics By: Azia Tariq, Staff Editor – With the sale of counterfeit drugs reaching an alarmingly higher rate than ever, The U.S Food and Drug Administration (FDA) in collaboration with the Skoll Global Threats Fund, the U.S. Pharmacopeia (USP), the National Institutes of Health (NIH), the Centers for Disease Control and Prevention (CDC), and the multi-agency… |
![]() |
In Wine There Is Truth...
October 1, 2014 - Featured , In the News / Politics By: Katharine Cimmino, Editor-in-Chief – Many articles and quick one-line stories have been cropping up on the internet boasting the benefits of drinking wine regularly. While headlines such as, “Drinking a Glass of Red Wine is the same as Getting an Hour of Exercise, Says New Study,” may make readers ecstatic that their drinking habits… |
![]() |
Ebola Outbreak in West Africa...
September 1, 2014 - Featured , In the News / Politics By: Azia Tariq, Staff Editor – The first recorded outbreak of the Ebola Zaire (ZEBOV), a strain of the ebola virus, occurred in 1976. Since then, three additional types of the deadly virus have been discovered: Sudan Ebola virus (SEBOV), Reston Ebola virus (REBOV), and Côte d’Ivoire Ebola virus (CIEBOV).1 The initial outbreak had, until… |
![]() |
Celiac Disease: Seeking Proper Treatment...
September 1, 2014 - Featured , In the News / Politics By: Sang Hyo Kim, Staff Editor – The Mayo Clinic reported in the American Journal of Gastroenterology that 1.8 million people in the United States suffer from celiac disease.1 More notably, of this population, over 75% of people are unaware that they even have this condition. While other studies have been conducted to determine the… |
![]() |
The Role of Pharmacists Expanding into the Emergency Ro...
August 1, 2014 - Featured , In the News / Politics By: Sherin Pathickal, PharmD Candidate c/o 2016 – In 2006, the Institute of Medicine reported that over 1.5 million people in the US suffered from a medication error, errors that not only cost the economy billions of dollars, but endangered countless lives.1 Each year, approximately 7,000 deaths occur to due to preventable medication related errors.2… |